Pathway Bioventures is a seed-stage life sciences fund investing in next-generation therapeutics, medical device, and diagnostics companies. The firm focuses on addressing important unmet medical needs and improving human health through breakthrough life sciences innovations.
Deal activity and portfolio updates would appear here
Connect your data source to see recent transactions